Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Pilot Study of Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-Cell Therapy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04409314
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:37.437674+00:00
Published At
2023-08-21T00:00:00+00:00
Record Updated At
2023-08-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Aggressive Non-Hodgkin Lymphoma", "Recurrent Diffuse Large B-Cell Lymphoma", "Recurrent High Grade B-Cell Lymphoma", "Recurrent Malignant Neoplasm", "Recurrent Plasma Cell Myeloma", "Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma", "Refractory Aggressive Non-Hodgkin Lymphoma", "Refractory Diffuse Large B-Cell Lymphoma", "Refractory High Grade B-Cell Lymphoma", "Refractory Malignant Neoplasm", "Refractory Plasma Cell Myeloma", "Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-08-21"
protocolSection.identificationModule.nctId
"NCT04409314"
protocolSection.identificationModule.officialTitle
"Pilot Study of Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-Cell Therapy"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Recurrent Aggressive Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Diffuse Large B-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent High Grade B-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Malignant Neoplasm (protocolSection.conditionsModule.conditions)
  • Recurrent Plasma Cell Myeloma (protocolSection.conditionsModule.conditions)
  • Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory Aggressive Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory Diffuse Large B-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory High Grade B-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory Malignant Neoplasm (protocolSection.conditionsModule.conditions)
  • Refractory Plasma Cell Myeloma (protocolSection.conditionsModule.conditions)
  • Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.